Screener
D&A at other companies
Other financials
Where this comes from
Reported directly by Privia Health Group, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Depreciation.
The source filing: Privia Health Group, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 8:45 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001759655-26-000064
| Line item | For the Six Months Ended June 30, 2026 | For the Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from operating activities | ||
| Net income | $13,444 | $9,334 |
| Adjustments to reconcile net income to net cash used in operating activities: | ||
| Depreciation | 291 | 415 |
| Amortization of intangibles | 6,346 | 4,069 |
| Stock-based compensation | 41,317 | 36,639 |
| Deferred income taxes, net | 3,683 | 2,671 |
| Changes in asset and liabilities: |
Item 1. Condensed Financial Statements (Unaudited)
FAQ
- What is Privia Health Group, Inc.'s D&A?
- Privia Health Group, Inc. (PRVA) reported D&A of $145K in Q2 2026.
- How has Privia Health Group, Inc.'s D&A changed year-over-year?
- Privia Health Group, Inc.'s D&A decreased by 22.5% year-over-year, from $187K to $145K.
- What is the long-term trend for Privia Health Group, Inc.'s D&A?
- Over 4 years (2021 to 2025), Privia Health Group, Inc.'s D&A has grown at a -10.5% compound annual growth rate (CAGR), from $1.15M to $739K.
- What does D&A mean?
- Total non-cash depreciation of tangible assets and amortization of intangible assets — the largest add-back to net income in the operating cash flow reconciliation.
Ask your AI about Privia Health Group, Inc.'s d&a.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude